<DOC>
	<DOCNO>NCT02025179</DOCNO>
	<brief_summary>This extension study enroll individual complete one year treatment parent protocol `` Effect Teriparatide , Vibration Combination Bone Mass Bone Architecture Chronic Spinal Cord Injury ( NCT01225055 ) '' . This study allow individual receive Teriparatide ( 20ug/day ) vibration ( 10 min/day ) parent study treat second year allow individual receive teriparatide-placebo opportunity full year teriparatide therapy . This study determine two year exposure teriparatide result great increase Bone Mass Density ( BMD ) see single year 's treatment . Subjects evaluate 6 12 month initiate treatment measurement bone density well bone marker formation resorption .</brief_summary>
	<brief_title>12 Month Extension Study Effect Teriparatide Bone People With Chronic Spinal Cord Injury ( SCI )</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<mesh_term>Bone Density Conservation Agents</mesh_term>
	<criteria>Enrollment , completion one year treatment , protocol `` Effect Teriparatide , Vibration Combination Bone Mass Bone Architecture Chronic Spinal Cord Injury '' . Adherence rate teriparatide use â‰¥60 % . Women childbearing potential men must agree use adequate contraception ( hormonal barrier method birth control ; abstinence ) prior study entry , duration study participation , 90 day follow completion therapy . Should woman become pregnant suspect pregnant participating study , inform treat physician immediately . A female childbearing potential woman ( regardless sexual orientation , undergone tubal ligation , remain celibate choice ) meet follow criterion : Has undergone hysterectomy bilateral oophorectomy ; Has naturally postmenopausal least 12 consecutive month ( i.e. , menses time precede 12 consecutive month ) . Ability understand willingness sign write informed consent . Individuals could tolerate teriparatide treatment . Individuals able return study visit . Patients may receive investigational agent . Other medical condition opinion investigator would preclude subject completing study</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Teriparatide</keyword>
	<keyword>Osteoporosis</keyword>
	<keyword>Spinal Cord Injury</keyword>
	<keyword>Bone Diseases</keyword>
	<keyword>Metabolic Bone Diseases</keyword>
	<keyword>Musculoskeletal Diseases</keyword>
	<keyword>Spinal Cord Diseases</keyword>
	<keyword>Central Nervous System Diseases</keyword>
	<keyword>Nervous System Diseases</keyword>
	<keyword>Nervous System</keyword>
	<keyword>Wounds Injuries</keyword>
	<keyword>Bone Density Conservation Agents</keyword>
	<keyword>Physiological Effects Drugs</keyword>
	<keyword>Pharmacologic Actions</keyword>
	<keyword>Vibration</keyword>
</DOC>